Newsletter | January 14, 2025

01.14.25 -- 2025 Predictions For AI Use In Biotech

SPONSOR

Webinar: The Next Frontier in mRNA: Modular Manufacturing for Scalable RNA-LNP Therapies

mRNA therapeutic manufacturers face challenges around mRNA products encapsulated in lipid nanoparticles (LNPs). Learn more about the Centre for Process Innovation’s first UK GMP-ready site, and how it meets diverse RNA product demands. Hear how new sustainable approaches for second-generation mRNA-LNP manufacturing are addressing manufacturing challenges and accelerating RNA-based vaccine and therapy development.

FOCUS ON MANUFACTURING

2025 Predictions For AI Use In Biotech

In this segment of the executive roundtable discussion, our panelists discuss the growing prevalence of AI and its implications, both good and bad. They share their thoughts on smart adoption and the need for regulatory guidance moving forward.

What's Next For Cell And Gene Therapies: Addressing Key Challenges

Delve into this exploration of the challenges and opportunities facing CGTs, including manufacturing, supply chain logistics, and the need for greater collaboration among stakeholders.

The Importance Of Operator Equipment Training

Learn why a strong commitment to operator training is essential to prevent production issues, ensure product quality, and safeguard patient safety.

Analyzing Serum-Free Media For Cell Therapy Applications

Identifying critical factors and their concentrations with an eye towards designing an ideally formulated, defined serum-free medium should be carried out using rational and systematic approaches.

Downstream Processing's Role In Optimizing RNA-LNP Drug Development

Explore the key aspects of lipid nanoparticle (LNP) development, including the essential downstream processes of tangential flow filtration (TFF) and normal flow filtration.

Using A Closed System For High-Density Cell Culture

Learn how to enhance your projects and support high-density cell cultures using a closed system or closed loop system to minimize contamination and improve safety.

Viral Vectors: Are We There Yet?

What must we do as an industry to continue the momentum of cell and gene therapies and ensure these revolutionary treatments become a reality for patients who need them?

Get Full Control Of Your T Cell Isolation

This study demonstrates the automated magnetic isolation of CD4/CD8+ cells from fresh or frozen leukapheresis using a functionally closed cell processing system paired with a modular application.

Co-Precipitation Of Metal Carbonate Templated Protein Microparticles

Automate the production of protein microparticles using an innovative method that offers a standardized and scalable solution for co-precipitation in biopolymer particle fabrication.

Choosing The Most Effective Transfection Reagent For Your Needs

Choosing the right transfection reagent can be confusing. This guide explores product names, their applications, and the importance of testing beyond labeled uses.

Digital Solutions Advance Your mRNA Manufacturing Workflow

Explore the advantages of paperless manufacturing, the importance of incorporating a digital strategy early in the process, and how digital solutions for mRNA manufacturing can help enhance production.

SPONSOR

With over 450 unique products in clinical development and 50 anticipated approvals by 2030, the evolving regulatory landscape for cell and gene therapies is more critical than ever. Don't miss your chance to gain expert insights! Join the next Cell & Gene Live for an exclusive digital panel discussion exploring forward-looking perspectives on this transformative field. Registration is free—thanks to the support of Thermo Fisher Scientific.

MANUFACTURING SOLUTIONS

A Modern Pharma MES Solution Offers The Best Of Old And New - MasterControl, Inc.

Propelling Cell And Gene Therapies From Concept To Commercialization - Roche CustomBiotech

An Introduction To Isolated Robotic Aseptic Filling Systems - AST

Quantum Flex Cell Expansion System - Terumo BCT

Connect With Cell & Gene: